Advanced Search

column
Progress of Novel Treatment Options for Glioma
ZHANG Jianning, LIU Congwei
2022, 49(6): 505-513. DOI: 10.3971/j.issn.1000-8578.2022.21.1514
Abstract PDF
Progress in Multidisciplinary Diagnosis and Treatment of Familial Brain Tumors
JIA Muyuan, LI Ze, LIU Yuyang, LIU Jialin, ZHENG Xiaoque, BAI Yunjuan, CHEN Ling
2022, 49(6): 514-521. DOI: 10.3971/j.issn.1000-8578.2022.21.1511
Abstract PDF
Advances in Treatment of Brain Metastasis from Lung Cancer
SUN Junzhao, CHENG Gang, ZHANG Jianning
2022, 49(6): 522-527. DOI: 10.3971/j.issn.1000-8578.2022.21.1456
Abstract PDF
Current Progress in Treatment of Glioma
ZHANG Yu, HE Kunyu, FENG Shiyu
2022, 49(6): 528-534. DOI: 10.3971/j.issn.1000-8578.2022.21.1337
Abstract PDF
Thirty Cases of Front-orbital Fibrous Dysplasia: Intraoperative Optic Canal Localization with Three-bits Method and Outcomes Evaluation
BU Bo, CHEN Lifeng, LI Chong, ZHU Ruyuan, ZHANG Yuanzheng, YU Xinguang, ZHANG Jianning
2022, 49(6): 535-540. DOI: 10.3971/j.issn.1000-8578.2022.21.1207
Abstract PDF
Progress and Comment on Surgical Treatment of Hepatoblastoma in Children
ZHAN Jianghua, WANG Zhiru
2022, 49(6): 541-545. DOI: 10.3971/j.issn.1000-8578.2022.21.1476
Abstract PDF
Immune Checkpoint PD-1-based Mechanisms of Tumor Immune Resistance and Strategies for Re-treatment After Drug Resistance
LI Yuxin, JIN Feng
2022, 49(6): 546-551. DOI: 10.3971/j.issn.1000-8578.2022.21.1296
Abstract PDF
Progress in Locoregional Interventional Therapy of Primary Hepatocellular Carcinoma
ZHOU Shi
2022, 49(6): 552-556. DOI: 10.3971/j.issn.1000-8578.2022.21.1370
Abstract PDF
Progress on Diagnosis and Treatment of Cervical High-grade Squamous Intraepithelial Lesion
YE Hong
2022, 49(6): 557-562. DOI: 10.3971/j.issn.1000-8578.2022.22.0022
Abstract PDF
LncRNA FENDRR Affect Proliferation, Migration and Apoptosis of Lung Squamous Cell Carcinoma H226 Cells via ERK/MAPK Signaling Pathway
ZHENG Jianzhou, BAI Yu, QI Chunjian
2022, 49(6): 563-568. DOI: 10.3971/j.issn.1000-8578.2022.21.1193
Abstract PDF
Screening of Molecular Markers of Cisplatin Resistance in Lung Adenocarcinoma and Functional Verification Based on TCGA Database
WANG Lin, HUANG Zixian, YOU Chengcheng, TAN Shunzi, HUANG Liming, HUANG Yiling
2022, 49(6): 569-574. DOI: 10.3971/j.issn.1000-8578.2022.21.1181
Abstract PDF
Effects of Pin1 on Proliferation and Apoptosis of HepG2 Cells Under Endoplasmic Reticulum Stress
JIANG Mingting, HUANG Jin, ZHENG Shuping
2022, 49(6): 575-580. DOI: 10.3971/j.issn.1000-8578.2022.21.1097
Abstract PDF
Transcriptome Analysis of Inhibitory Effect of Astaxanthin Against HepG2 Cell Lines
XU Huan, WANG Guangli, LI Tingming, WANG Wei, DONG Dandan
2022, 49(6): 581-585. DOI: 10.3971/j.issn.1000-8578.2022.21.1231
Abstract PDF
Expression of MAD2L1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment
LIU Yingbo, LIU Xiaohong, RU Meihua, LI Jianqiang
2022, 49(6): 586-592. DOI: 10.3971/j.issn.1000-8578.2022.21.1222
Abstract PDF
Diagnostic Value of Serum LncRNAs for Bone Metastasis in Lung Cancer
ZHANG Peng, GAO Min, FENG Feifei, LI Mengyuan, LIU Jinyan, HUANG Lingling
2022, 49(6): 593-598. DOI: 10.3971/j.issn.1000-8578.2022.21.1047
Abstract PDF
Prognostic Role of Immune-related Genes in Hepatocellular Carcinoma
WANG Jue, JIN Zongrui, WANG Wei, YI Qilin, WANG Jilong, ZHU Hai, XU Banghao, GUO Ya, WEN Zhang
2022, 49(6): 599-605. DOI: 10.3971/j.issn.1000-8578.2022.21.1240
Abstract PDF
LncRNA Prognostic Risk Scoring Model for Gastrointestinal Tumors Based on TCGA Database
LI Menghan, XIAO Qiong, GAO Peng, FU Yu, SUN Chenrui, SONG Yongxi
2022, 49(6): 606-611. DOI: 10.3971/j.issn.1000-8578.2022.21.1159
Abstract PDF
Revision for Aseptic Loosening of Tumor Prosthesis in Lower Limbs
XU Hairong, LI Yuan, SHAN Huachao, YU Feng, NIU Xiaohui
2022, 49(6): 612-615. DOI: 10.3971/j.issn.1000-8578.2022.22.0176
Abstract PDF
Research Progress on Regulatory Mechanism of Ubiquitin Modification on Warburg Effect in Malignant Tumors
WANG Fengli, HU Jing
2022, 49(6): 616-622. DOI: 10.3971/j.issn.1000-8578.2022.21.1123
Abstract PDF
Research Progress of Alternative Splicing in Oral Squamous Cell Carcinoma
WU Xiaofen, SUN Rui
2022, 49(6): 623-627. DOI: 10.3971/j.issn.1000-8578.2022.21.1210
Abstract PDF
Clinical Value of 131I in Diagnosis and Treatment of Recurrent Papillary Thyroid Carcinoma
JING Zhengjun, ZHANG Yaqi, BIE Shuang, FAN Qianyu, CHEN Jian
2022, 49(6): 628-633. DOI: 10.3971/j.issn.1000-8578.2022.21.1214
Abstract PDF
A Case Report of Apatinib Mesylate in Treatment of Advanced Alveolar Soft Part Sarcoma with Multiple Metastases
ZHU Xianmin, DONG Shuang, TANG Jing, XIE Rong, ZHONG Yi, WU Huijing, HU Sheng
2022, 49(6): 634-636. DOI: 10.3971/j.issn.1000-8578.2022.21.1236
Abstract PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：